You are here

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Durvalumab activity in previously treated patients who stopped durvalumab without disease progression

 

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

AbstractFullPdf
Aug 202012231223335
Sep 2020757757219
Oct 202021321362
Nov 202014314238
Dec 202016016028
Jan 202114414439
Feb 202115215236
Mar 202115715786
Apr 202115415434
May 202117717740
Jun 202110410434
Jul 202110510525
Aug 202110510527
Sep 202110010024
Oct 2021838341
Nov 2021646433
Dec 2021656618
Jan 2022687216
Feb 2022515924
Mar 2022777824
Apr 2022858512
May 2022838426
Jun 202272738
Jul 2022576021
Aug 2022565714
Sep 2022616339
Oct 2022485023
Nov 2022505026
Dec 2022646411
Jan 2023555616
Feb 2023949417
Mar 2023626331
Apr 2023363610
May 202361619
Jun 202353539
Jul 2023363614
Aug 2023404225
Sep 2023555514
Oct 2023454513
Nov 2023454511
Dec 202334345
Jan 2024192015
Feb 2024262616
Mar 2024343565
Total537354021633